Let Us Know You Liked What You Heard
What does 13 months on GLP-1 actually look like from the inside — not the highlight reel version, but the full case study with real numbers, real side effects, and the findings that never came up in a single doctor's appointment?
Theresa opens the lab.
64 pounds down on Zepbound (tirzepatide), with 30 pounds to go, she puts her actual data on the table — her week-by-week Month 1 breakdown, her complete dosage timeline from 2.5mg to 12.5mg, and how her results compare against the clinical trial averages. Then she goes where the prescription doesn't.
In this episode:
→ The gastrointestinal side effects they describe as "mild" — and what that language actually means at every dose increase
→ The skin elasticity loss that showed up in a massage studio mirror and what it revealed about collagen, rapid weight loss, and what women in midlife are not being told
→ The silent nutritional drain — the specific micronutrients GLP-1 appetite suppression depletes over months, why they are non-negotiable for women over 40, and the exact labs to ask your doctor for at your next appointment
→ The question at the center of it all — was it worth it — and the honest answer that doesn't fit on a before-and-after post
This episode is for the woman already on a GLP-1 medication who is seeing changes in her body she wasn't prepared for. It is also for the woman considering it who wants the complete picture before she starts. Either way — this is the conversation your prescription didn't come with.
You deserved this information on Day 1. Here it is now.
📖 Don't Quit Yet — Revised & Expanded Edition Strategy, workbook, and tools for women in transition. → DownLoad HERE
🎙️ She's Not Done Yet with Theresa — Ms. Mogul New episodes dropping regularly. Subscribe so you never miss one.